Notes to SEFA
The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of certain subsidiaries of Temple University Health System, Inc. (the “Health System”) under programs of the federal government for the year ended June 30, 2025. The Schedule includes the expenditures of Institute for Cancer Research, doing business as the Research Institute of Fox Chase Cancer Center (a wholly owned subsidiary of American Oncologic Hospital), Temple University Hospital, Inc., and Temple Faculty Practice Plan, Inc. Because the Schedule presents only a selected portion of the operations of the Health System, it is not intended to, and does not, present the financial position, revenues, expenses, and changes in net assets of the Health System. For the purposes of the Schedule, federal awards include all grants, contracts, and similar agreements entered into directly between the Health System and agencies or departments of the federal government and all subawards to the Health System by nonfederal organizations pursuant to federal grants, contracts, and similar agreements. BASIS OF ACCOUNTING: SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS — The Schedule is presented using the accrual basis of accounting. The amounts reported in the schedule as expenditures may differ from certain financial reports submitted to federal, state or city funding agencies due to those reports being submitted on either a cash or modified accrual basis of accounting.
The Health System has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.
The Health System received state financial assistance from the Commonwealth of Pennsylvania, passed through the Pennsylvania Department of Health (PADOH). The PADOH financial assistance is not reflected in the Schedule of Expenditures of Federal Awards. These PADOH financial assistance awards are not audited, as they did not meet the threshold for audit.
The negative amounts shown in the Schedule resulted from adjustments or credits made in the normal course of business to amounts reported as expenditures in prior fiscal years.